LBO — SUMMIT PACIFIC MEDICAL CENTER
IRR: 17.8% | MOIC: 2.27x
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
17.8%
IRR
2.27x
MOIC
$68.9M
Entry EV
$108.9M
Exit EV
$35.5M
Equity Invested
Sources & Uses
S&UTotal · $68.9M| Item | Amount | % | Distribution |
|---|---|---|---|
| Senior Debt | $26.8M | 38.8% | |
| Sub Debt | $6.7M | 9.7% | |
| Equity | $35.5M | 51.5% | |
| Enterprise Value | $66.9M | 97.1% | |
| Transaction Fees | $2.0M | 2.9% | |
| Total Uses | $68.9M | 100.0% |
Interpretation
INTAt 2.27x MOIC and 17.8% IRR over 5 years, this deal meets the 15-20% range — acceptable with operational upside.
Key drivers: Check the EBITDA bridge to identify highest-probability levers, the debt schedule for leverage trajectory, or the challenge solver to see what breaks the deal.
Returns Waterfall
WFL| Component | Value |
|---|---|
| Exit Ebitda | $10.4M |
| Exit Ev | $108.9M |
| Net Debt At Exit | $28.3M |
| Equity At Exit | $80.6M |
| Equity Invested | $35.5M |
| Total Value Created | $45.1M |
| Value From Growth | $38.7M |
| Value From Multiple | $3.3M |
| Value From Deleveraging | $5.1M |